HomeRNA • NASDAQ
add
Atrium Therapeutics Inc
Previous close
$13.09
Day range
$12.95 - $13.25
Year range
$11.95 - $73.06
Market cap
224.20M USD
Avg Volume
2.42M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 859.00K | -71.11% |
Operating expense | 15.67M | 819.24% |
Net income | -29.14M | -153.09% |
Net profit margin | -3.39K | -775.95% |
Earnings per share | — | — |
EBITDA | -28.98M | -367.95% |
Effective tax rate | -0.12% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | 8.35M | 16.24% |
Total liabilities | 71.07M | 4.06% |
Total equity | -62.71M | — |
Shares outstanding | 15.51M | — |
Price to book | -3.24 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -29.14M | -153.09% |
Cash from operations | -19.25M | -132.99% |
Cash from investing | -879.00K | -303.21% |
Cash from financing | 20.13M | 137.37% |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2025
Website
Employees
47
